Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
NCT01444794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-11-05
Summary
The purpose of the protocol is to assess the responder rate as defined by the achievement of the primary goal from the Goal Attainment Scale following one botulinum toxin type-A (BoNT-A) injection cycle in accordance with routine practices.
Conditions
- Spasticity
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-09-30
- Completion
- 2013-02-28
Countries
- Spain
Study Locations
More Related Trials
-
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
NCT01239628 ·Status: TERMINATED
-
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
NCT02454803 ·Status: COMPLETED
-
Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
NCT05224349 ·Status: COMPLETED
-
A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.
NCT04396704 ·Status: COMPLETED
-
ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity
NCT02275312 ·Status: COMPLETED
-
BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity
NCT01575054 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients
NCT02390206 ·Status: COMPLETED
-
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT01392300 ·Status: COMPLETED ·Phase: PHASE3
-
Dysport® Adult Lower Limb Spasticity Study
NCT01249404 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
NCT01464307 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A
NCT04340336 ·Status: COMPLETED
-
Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb
NCT01829763 ·Status: UNKNOWN ·Phase: PHASE3
-
Spastic Cocontractions and Limitation of Active Movements Before and After Treatment During Injection of Botulinum Toxin
NCT03453008 ·Status: UNKNOWN
-
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
NCT06811142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults
NCT02505802 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
Dysport® Adult Lower Limb Spasticity Follow-on Study
NCT01251367 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
NCT02321436 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
NCT01910363 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot
NCT03044080 ·Status: COMPLETED ·Phase: PHASE4
-
Efficiency of Botulinum Toxin Injection for Spastic Equinovarus Foot in Post Stroke Hemiparetic Patients
NCT03405948 ·Status: COMPLETED ·Phase: NA
-
Observational Longitudinal Study on the Outbreak and Management of Stroke Related Spasticity
NCT05379413 ·Status: UNKNOWN
-
The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity
NCT05887479 ·Status: WITHDRAWN ·Phase: PHASE4